|
01 May 2007 |
Cardiome Announces In-Licensing Agreement with Eli Lilly and Company
|
|
01 May 2007 |
Apollo develops needle-free topical vaccine
|
|
28 Apr 2007 |
Optaflu(R), the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval
|
|
28 Apr 2007 |
Kyowa Hakko in-licenses ARQ 197, an anticancer agent in clinical development, from the US company ArQule.
|
|
27 Apr 2007 |
Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery
|
|
27 Apr 2007 |
Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
|
|
27 Apr 2007 |
Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
|
|
27 Apr 2007 |
SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
|
|
27 Apr 2007 |
Ranbaxy Receives Final Us FDA Approval to Manufacture and Market Zolpidem Tablets in Usa
|
|
27 Apr 2007 |
Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
|
|
27 Apr 2007 |
Alchemia reports preliminary positive efficacy data from HyCAMP Phase II trial
|
|
26 Apr 2007 |
MediGene Completes Patient Recruitment for Clinical Phase II Trial of EndoTAG(R)-1
|
|
26 Apr 2007 |
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
|
|
26 Apr 2007 |
Ranbaxy Receives Us Fda Approval To Manufacture And Market Pravastatin Sodium Tablets In Usa
|
|
26 Apr 2007 |
ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
|
|
26 Apr 2007 |
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
|
|
26 Apr 2007 |
Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
|
|
26 Apr 2007 |
OctoPlus obtains full rights to PolyActive drug delivery technology from IsoTis
|
|
25 Apr 2007 |
Beyond biogenerics: the real threats for therapeutic proteins
|
|
25 Apr 2007 |
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
|
|
25 Apr 2007 |
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
|
|
25 Apr 2007 |
Wockhardt receives US FDA approval for anti-hypertensive drug
|
|
25 Apr 2007 |
Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
|
|
24 Apr 2007 |
AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion
|
|
24 Apr 2007 |
Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment
|
